Intravenous Solutions Market Size, Share & Trends Report

Intravenous Solutions Market Size, Share & Trends Analysis Report By Product (TPN, PPN), By Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids) By Region (Asia Pacific, North America), And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-137-5
  • Number of Pages: 114
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the intravenous solutions market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for intravenous solutions market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of intravenous solutions market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Intravenous Solutions Market Categorization:

The intravenous solutions market was categorized into three segments, namely product (Total Parenteral Nutrition, Peripheral Parenteral Nutrition), nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids, Parenteral Lipid Emulsion), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The intravenous solutions market was segmented into product, nutrients, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The intravenous solutions market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Intravenous solutions market companies & financials:

The intravenous solutions market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Fresenius Kabi AG: Fresenius Kabi AG is a subsidiary of Fresenius SE & Co. KGaA, a global healthcare group. The company is involved in pharmaceutical infusions, transfusion, and clinical nutrition segments. Fresenius SE & Co. KGaA has independent business segments, including Fresenius Kabi, Fresenius Vamed, Fresenius Medical Care, and Fresenius Helios. It has a presence in over 100 countries. Fresenius Kabi AG operates in various segments, including biosimilar, intravenous drugs, clinical nutrition, medical devices/transfusion technology, and infusion therapy. It is also involved in supplying transfusion technology products and medical devices. Its clinical nutrition segment includes products focusing on enteral nutrition, parenteral nutrition, and infusion disposables. The company has a global presence across North America, Latin America, Asia Pacific, Africa, Europe, and the Middle East through its sales & marketing organizations, production sites, and Research & Development (R&D) centers. In January 1999, Fresenius Kabi got its name after combining Fresenius Group’s pharmaceutical division and acquiring Pharmacia and Upjohn (jointly known as Kabi).

  • B. Braun SE: B. Braun SE manufactures medical technology and pharmaceutical products worldwide. The company also develops trendsetting standards and effective solutions in 18 therapy fields of the healthcare industry. It manages operations in 18 therapy fields through four divisions: B. Braun Avitum, Outpatient Market, Aesculap, and Hospital Care. The company offers nearly 5,000 products, of which it manufactures 4,750 products. These products include solutions and consumable materials required for pain, infusion, nutrition therapies, infusion pumps, infusion systems, surgical instruments, disinfection products, suture materials, dialysis accessories & equipment, hip & knee implants, and wound care. The company has manufacturing plants in Germany, China, India, Spain, Romania, the U.S., Japan, Switzerland, France, Hungary, the Dominican Republic, Brazil, and Malaysia. The company has a presence in 61 countries, including the U.S., Mexico, Argentina, Brazil, Kenya, Spain, Italy, Switzerland, India, China, Russia, Indonesia, Australia, New Zealand, South Korea, and Japan.

  • Baxter: Baxter designs, manufactures, and sells medical devices in North America, Europe, Latin America, & Asia Pacific through its subsidiaries. The company operates in two reportable segments: BioScience and Medical Products. The BioScience segment provides plasma-based proteins and therapies for the treatment of various diseases, such as hemophilia, burns & shocks, immune deficiencies, alpha-1 antitrypsin deficiency, and other blood-related & chronic conditions. This segment also provides healthcare products and vaccines. The Medical Products business unit manufactures premixed drugs & drug reconstitution systems, intravenous solutions & administration sets, syringes & prefilled vials for injectable drugs, and drug reconstitution systems, among others.

  • Otsuka Pharmaceutical Co., Ltd.: Otsuka Pharmaceutical Co., Ltd. operates two core business units—pharmaceuticals and nutraceuticals— to manufacture, distribute, export, and import pharmaceuticals, nutraceuticals, clinical testing equipment, food products, & other related products. The nutraceutical business focuses on developing consumer food and cosmetics that maintain & promote day-to-day well-being. The Otsuka group of companies forms the entire healthcare enterprise standing on its four business pillars of pharmaceuticals, nutraceuticals, consumer products, and others, and has a global presence of 196 companies in 31 countries.

  • Grifols, S.A.: Grifols S.A. is a global company operating in the health and wellbeing space. It is categorized into four divisions: diagnostic, hospital, bioscience, and biosupplies. The company specializes in plasma-derived therapies, intravenous therapies, and clinical nutrition. The bioscience division focuses on R&D, manufacturing, and marketing products for hemotherapy, neurology, intensive care, & clinical nutrition. Grifols Laboratories has large manufacturing capabilities for producing intravenous and parenteral solutions. The hospital division and Contract Development and Manufacturing Organization (CDMO) subsidiary are responsible for developing, packaging, and distributing parenteral clinical nutrition solutions. The company has 16 manufacturing plants and operates commercially in over 100 countries.

  • Pfizer, Inc.: Pfizer, Inc. is a global biopharmaceutical company involved in manufacturing, R&D, and marketing healthcare products. The company operates in two segments: Innovative Health (IH) and Essential Health (EH). The IH segment deals with developing and commercializing novel medicines & vaccines for key therapeutic areas, such as immunology, oncology, and rare diseases. The EH segment includes brands that have lost market exclusivity or those already off-patent. The company collaborated with hospitals, clinics, retailers, wholesalers, and other government agencies. In 2015, Pfizer acquired Hospira and increased its presence & capabilities in the injection and infusion market.

  • JW Life Science: JW Life Science is a leading provider of life sciences products and services. Established in 2002, the company has a global presence in over 20 countries. JW Life Science offers a wide range of products and services, including research reagents, laboratory equipment, and contract research services. The company is committed to providing high-quality products and services to its customers and is dedicated to advancing life sciences research.

  • Amanta Healthcare: Amanta Healthcare is a leading manufacturer and marketer of sterile liquid parenteral in India. The company was established in 1997 and has become a global player in over 77 countries. The company’s products are used in hospitals, clinics, and other healthcare settings worldwide. The company is committed to providing high-quality products and services to its customers and is dedicated to advancing the healthcare industry.

  • ICU Medical: ICU Medical is a global medical device company that develops, manufactures, and distributes products used in infusion therapy and critical care. The company’s products are designed to improve the safety and efficiency of infusion therapy. ICU Medical’s products include IV pumps, needle-free connectors, closed system transfer devices, and vascular access devices. The company also offers a variety of services, such as clinical education & training and technical support. ICU Medical is committed to providing high-quality products and services to its customers. The company focuses on innovation and has over 500 products used in hospitals and clinics worldwide.

  • Vifor Pharma: Vifor Pharma, a global pharmaceutical company, is a part of the Haussmann’s Pharmacy foundation known as the Galenica Group, founded in 1872. Galenica acquired Vifor Pharma in 1977 and is currently a fully integrated pharma company of this group. The company focuses on nephrology, iron deficiency, and cardiorenal therapies. It operates in three franchises: infectious diseases, Iron, and Vifor Fresenius Medical Care Renal Pharma Ltd. (a joint company with Fresenius Kabi). The Iron franchise focuses on therapeutic areas, such as oncology, cardiology, and gastroenterology. The infectious diseases franchise focuses on pulmonary tract diseases, urinary tract infections, etc.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Intravenous Solutions Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Intravenous Solutions Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon